First Wave BioPharma, Inc. FWBI
2.96 +2.96
Day range unavailable
52-week range unavailable
Analyst view
Consensus: buy
Buy
Price target (mean) 36.00
Ratings (-1m) 1 1 buy · 0 hold · 0 sell
- Strong buy0
- Buy1
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- 1 month ago 1
- 2 months ago 1
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.32 | -0.32 – -0.32 | -37.80 | +99.2% | 0 | 0.0% | 1 |
| Next quarter | -0.37 | -0.37 – -0.37 | -9.20 | +96.0% | 0 | 0.0% | 1 |
| Current year | -1.80 | -1.80 – -1.80 | -47.88 | +96.2% | 0 | 0.0% | 1 |
| Next year | -1.55 | -1.55 – -1.55 | -1.80 | +13.9% | 0 | 0.0% | 1 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Sep 18, 2023 | Roth MKM | Reiterated | Buy | Buy |
| Jul 13, 2023 | HC Wainwright & Co. | Downgrade | Buy | Neutral |
| Jun 28, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jun 12, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 14, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Apr 25, 2023 | HC Wainwright & Co. | Reiterated | — | Buy |
| Apr 4, 2023 | HC Wainwright & Co. | Maintained | — | Buy |
| Mar 8, 2023 | HC Wainwright & Co. | Reiterated | — | Buy |
| Feb 2, 2023 | HC Wainwright & Co. | Reiterated | — | Buy |
| Jan 30, 2023 | HC Wainwright & Co. | Reiterated | — | Buy |
| Jan 25, 2023 | HC Wainwright & Co. | Reiterated | — | Buy |
